YM BioSciences Inc. - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWIRE) -- 09/21/2012 -- YM BioSciences Inc. - Product Pipeline Review - 2012 provides data on the YM BioSciences Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- YM BioSciences Inc. - Brief YM BioSciences Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of YM BioSciences Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of YM BioSciences Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the YM BioSciences Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate YM BioSciences Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of YM BioSciences Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the YM BioSciences Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with YM BioSciences Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of YM BioSciences Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of YM BioSciences Inc.; YM BioSciences Inc. - Key Therapeutics; YM BioSciences Inc. - Pipeline Overview and Promising Molecules; YM BioSciences Inc. - News; YM BioScience

To view table of contents for this market report please visit: